Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-16

FDA Approved: MUPIROCIN — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals' original ANDA for mupirocin topical ointment, authorizing its marketing as a generic antibiotic for topical use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mupirocin (Mupirocin)

Snippet

ORIG AP for MUPIROCIN (MUPIROCIN)